Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis.
Aurinia said fourth-quarter revenue totaled $23.4 million, which was down from revenue of $50.03 million year-over-year. The company reported a quarterly earnings loss of 25 cents per share, which was worse than the loss of 6 cents per share in the fourth quarter of 2020.
